Product
GB-5001D
1 clinical trial
1 indication
Indication
Alzheimer's diseaseClinical trial
An Open-label, Active-controlled, Parallel and Dose-escalation, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Intramuscular (IM) and Subcutaneous (SC) Donepezil (GB-5001) Injections Versus Donepezil Oral Tablet (Aricept®) in Healthy Male VolunteersStatus: Recruiting, Estimated PCD: 2024-09-17